Related Experiment Videos
[Immunoglobulin stabilizes plaque formation in experimental atherosclerosis]
Kana Shimada1, Chiharu Kishimoto, Takaaki Okabe
1Department of Cadiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto.
Journal of Cardiology
|June 28, 2006
Summary
Immunoglobulin treatment significantly reduced fatty lesions in advanced atherosclerosis in mice. This therapy suppressed inflammatory cell infiltration, suggesting plaque stabilization via Fc receptors.
Area of Science:
- Cardiovascular Research
- Immunology
- Pharmacology
Background:
- Atherosclerosis is a chronic inflammatory disease.
- Immunoglobulin therapy is known to suppress early-stage atherosclerosis.
- The effect of immunoglobulin on advanced atherosclerosis remains unclear.
Purpose of the Study:
- To investigate the efficacy of immunoglobulin treatment in advanced atherosclerosis.
- To determine if immunoglobulin impacts atherosclerotic lesion development and inflammatory markers.
- To confirm the role of Fc receptors in immunoglobulin's anti-atherosclerotic effects.
Main Methods:
- Atherosclerosis was induced in apolipoprotein E-deficient mice using a high-fat diet.
- Mice with established lesions received intact immunoglobulin or F(ab')2 fragments.
- Aortic tissues were analyzed for atherosclerotic lesions and CD4+ cell infiltration.
Main Results:
- Intact immunoglobulin significantly suppressed fatty streak lesions compared to saline control.
- Inflammatory cell infiltration and CD4+ cell expression were reduced by intact immunoglobulin.
- These findings suggest a therapeutic benefit of immunoglobulin in advanced atherosclerosis.
Conclusions:
- Immunoglobulin treatment effectively suppresses fatty lesion development in advanced atherosclerosis.
- The therapy may stabilize plaques by reducing inflammatory cell expression.
- Fc receptor engagement is crucial for immunoglobulin's anti-atherosclerotic action.